DAWN
Price
$7.19
Change
+$0.24 (+3.45%)
Updated
Jun 6 closing price
Capitalization
728.8M
66 days until earnings call
IDYA
Price
$21.73
Change
+$0.63 (+2.99%)
Updated
Jun 6 closing price
Capitalization
1.9B
66 days until earnings call
Interact to see
Advertisement

DAWN vs IDYA

Header iconDAWN vs IDYA Comparison
Open Charts DAWN vs IDYABanner chart's image
Day One Biopharmaceuticals
Price$7.19
Change+$0.24 (+3.45%)
Volume$1.45M
Capitalization728.8M
IDEAYA Biosciences
Price$21.73
Change+$0.63 (+2.99%)
Volume$789.21K
Capitalization1.9B
DAWN vs IDYA Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. IDYA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a StrongBuy and IDYA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (DAWN: $7.19 vs. IDYA: $21.73)
Brand notoriety: DAWN and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 107% vs. IDYA: 52%
Market capitalization -- DAWN: $728.8M vs. IDYA: $1.9B
DAWN [@Biotechnology] is valued at $728.8M. IDYA’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 6 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 3 bearish.
  • IDYA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both DAWN and IDYA are a good buy in the short-term.

Price Growth

DAWN (@Biotechnology) experienced а +12.70% price change this week, while IDYA (@Biotechnology) price change was +9.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

DAWN is expected to report earnings on Aug 12, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.9B) has a higher market cap than DAWN($729M). IDYA YTD gains are higher at: -15.447 vs. DAWN (-43.252). DAWN has higher annual earnings (EBITDA): -188.76M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. DAWN (473M). DAWN has less debt than IDYA: DAWN (2.92M) vs IDYA (26M). DAWN has higher revenues than IDYA: DAWN (162M) vs IDYA (7M).
DAWNIDYADAWN / IDYA
Capitalization729M1.9B38%
EBITDA-188.76M-356.46M53%
Gain YTD-43.252-15.447280%
P/E RatioN/AN/A-
Revenue162M7M2,314%
Total Cash473M693M68%
Total Debt2.92M26M11%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNIDYA
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISCIX49.12N/A
N/A
Federated Hermes Intl Small-Mid Co IS
JUESX24.90N/A
N/A
JPMorgan US Equity I
SFGIX13.01N/A
N/A
Seafarer Overseas Gr and Income Investor
MVTIX10.78N/A
N/A
Transamerica Mid Cap Value Opps I
RSSRX24.61N/A
N/A
Victory RS Select Growth R6